June 5, 2017 / 7:26 AM / 3 months ago

BRIEF-Chiome Bioscience receives TROP-2 antibody related patent in China

June 5 (Reuters) - Chiome Bioscience Inc

* Says it received a TROP-2 antibody related patent, Anti-Human Trop-2 Antibody Having Antitumor Activity In Vivo, (application No.201280057258.4) in China on June 5

Source text in Japanese:goo.gl/MD18oX

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below